HC Surgical Specialists Limited

Catalist:1B1 Stock Report

Market Cap: S$43.1m

HC Surgical Specialists Past Earnings Performance

Past criteria checks 5/6

HC Surgical Specialists's earnings have been declining at an average annual rate of -11.8%, while the Healthcare industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 0.3% per year. HC Surgical Specialists's return on equity is 27.2%, and it has net margins of 20.2%.

Key information

-11.8%

Earnings growth rate

-11.9%

EPS growth rate

Healthcare Industry Growth9.7%
Revenue growth rate0.3%
Return on equity27.2%
Net Margin20.2%
Last Earnings Update31 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How HC Surgical Specialists makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

Catalist:1B1 Revenue, expenses and earnings (SGD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 May 2419400
29 Feb 2419400
30 Nov 2319400
31 Aug 2319400
31 May 2319300
28 Feb 2319300
30 Nov 2219400
31 Aug 2219500
31 May 2219600
28 Feb 2221700
30 Nov 2123800
31 Aug 2123800
31 May 2123800
28 Feb 2121700
30 Nov 2018700
31 Aug 2017500
31 May 2017400
29 Feb 2019400
30 Nov 1920710
31 Aug 1919810
31 May 1918710
28 Feb 1917810
30 Nov 1817410
31 Aug 1816410
31 May 1816410
28 Feb 1815420
30 Nov 1713410
31 Aug 1711210
31 May 179110
28 Feb 179100
30 Nov 168200
31 Aug 168200
31 May 168300
31 May 157300
31 May 147300

Quality Earnings: 1B1 has high quality earnings.

Growing Profit Margin: 1B1's current net profit margins (20.2%) are higher than last year (15.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 1B1's earnings have declined by 11.8% per year over the past 5 years.

Accelerating Growth: 1B1's earnings growth over the past year (31.8%) exceeds its 5-year average (-11.8% per year).

Earnings vs Industry: 1B1 earnings growth over the past year (31.8%) exceeded the Healthcare industry -26%.

Return on Equity

High ROE: 1B1's Return on Equity (27.2%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 05:14
End of Day Share Price 2024/12/17 00:00
Earnings2024/05/31
Annual Earnings2024/05/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

HC Surgical Specialists Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution